1. Home
  2. ORIC vs VINP Comparison

ORIC vs VINP Comparison

Compare ORIC & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • VINP
  • Stock Information
  • Founded
  • ORIC 2014
  • VINP 2009
  • Country
  • ORIC United States
  • VINP Brazil
  • Employees
  • ORIC N/A
  • VINP N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • VINP Investment Managers
  • Sector
  • ORIC Health Care
  • VINP Finance
  • Exchange
  • ORIC Nasdaq
  • VINP Nasdaq
  • Market Cap
  • ORIC 974.1M
  • VINP 636.2M
  • IPO Year
  • ORIC 2020
  • VINP 2021
  • Fundamental
  • Price
  • ORIC $10.71
  • VINP $10.06
  • Analyst Decision
  • ORIC Strong Buy
  • VINP Strong Buy
  • Analyst Count
  • ORIC 10
  • VINP 2
  • Target Price
  • ORIC $17.33
  • VINP $13.50
  • AVG Volume (30 Days)
  • ORIC 886.3K
  • VINP 36.7K
  • Earning Date
  • ORIC 11-11-2025
  • VINP 11-06-2025
  • Dividend Yield
  • ORIC N/A
  • VINP 6.46%
  • EPS Growth
  • ORIC N/A
  • VINP N/A
  • EPS
  • ORIC N/A
  • VINP 0.50
  • Revenue
  • ORIC N/A
  • VINP $153,475,995.00
  • Revenue This Year
  • ORIC N/A
  • VINP $67.62
  • Revenue Next Year
  • ORIC N/A
  • VINP $14.50
  • P/E Ratio
  • ORIC N/A
  • VINP $20.04
  • Revenue Growth
  • ORIC N/A
  • VINP 76.11
  • 52 Week Low
  • ORIC $3.90
  • VINP $8.66
  • 52 Week High
  • ORIC $14.67
  • VINP $10.99
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 55.85
  • VINP 54.16
  • Support Level
  • ORIC $10.36
  • VINP $9.75
  • Resistance Level
  • ORIC $11.20
  • VINP $10.09
  • Average True Range (ATR)
  • ORIC 0.49
  • VINP 0.23
  • MACD
  • ORIC 0.06
  • VINP -0.01
  • Stochastic Oscillator
  • ORIC 67.35
  • VINP 72.09

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

Share on Social Networks: